Table 1 Outcome measures studied
Number | Outcome measures |
|---|---|
1 | Changes in the size of ulcerative lesions |
2 | Histopathological changes of the oral mucosa |
3 | Reduction in the expression of inflammatory markers (TNFα, IL-1β, IL-6, IL-8) |
4 | Inhibition of key inflammatory pathways (NF-κB and COX2) |
5 | Reduction in microbial growth |
6 | Pain-related behavioural changes |